April 2014—Terumo BCT received FDA 510(k) clearance for red blood cell exchange on the Spectra Optia Apheresis System. This option gives clinicians the flexibility to perform exchange, depletion, and depletion/exchange procedures on the Spectra Optia system and to tailor each procedure for the transfusion management of sickle cell disease in adults and children.
Terumo BCT, 303-205-2546